Anti-Jagged1 antigen binding proteins

A method of treating a subject with a condition related to lung disease, wherein the lung disease is a disease of the airways, the method comprising administering to the subject a therapeutically effective amount of an antigen binding protein that specifically binds to a human Jagged1 polypeptide, wherein the antigen binding protein is an antibody or a fragment thereof, and wherein the antibody comprises a CDRL1, a CDRL2, a CDRL3, a CDRH1, a CDRH2, and a CDRH3, wherein CDRL1 comprises SEQ ID NO:

• 98, CDRL2 comprises SEQ ID NO:
• 99, CDRL3 comprises SEQ ID NO:
• 100, CDRH1 comprises SEQ ID NO:
• 230, CDRH2 comprises SEQ ID NO:
• 231, and CDRH3 comprises SEQ ID NO:
• 232.